Wilson & Boucher Capital Management LLC Lowers Stock Position in CVS Health Co. (NYSE:CVS)

Wilson & Boucher Capital Management LLC lowered its position in shares of CVS Health Co. (NYSE:CVS) by 2.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 8,600 shares of the pharmacy operator’s stock after selling 202 shares during the quarter. Wilson & Boucher Capital Management LLC’s holdings in CVS Health were worth $541,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. MidAtlantic Capital Management Inc. purchased a new position in shares of CVS Health in the 3rd quarter worth about $25,000. Livelsberger Financial Advisory purchased a new position in shares of CVS Health in the 3rd quarter worth about $31,000. Legacy Investment Solutions LLC purchased a new position in shares of CVS Health in the 3rd quarter worth about $31,000. Reston Wealth Management LLC purchased a new position in shares of CVS Health in the 3rd quarter worth about $32,000. Finally, Kathleen S. Wright Associates Inc. purchased a new position in shares of CVS Health in the 3rd quarter worth about $33,000. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Analyst Ratings Changes

CVS has been the subject of several research analyst reports. TD Cowen lifted their price objective on CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a report on Monday, November 25th. UBS Group lifted their price objective on CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a report on Thursday, November 7th. Evercore ISI lifted their price objective on CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a report on Tuesday, October 8th. Wells Fargo & Company upgraded CVS Health from an “equal weight” rating to an “overweight” rating and lifted their price objective for the stock from $60.00 to $66.00 in a report on Monday, November 18th. Finally, Deutsche Bank Aktiengesellschaft upgraded CVS Health from a “hold” rating to a “buy” rating and set a $66.00 price objective for the company in a report on Tuesday, December 3rd. One investment analyst has rated the stock with a sell rating, six have given a hold rating and fourteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $70.50.

CVS Health Stock Down 1.6 %

Shares of CVS opened at $55.15 on Wednesday. The stock has a market capitalization of $69.40 billion, a price-to-earnings ratio of 14.00, a price-to-earnings-growth ratio of 0.95 and a beta of 0.54. CVS Health Co. has a 1 year low of $52.71 and a 1 year high of $83.25. The business’s 50 day simple moving average is $59.21 and its 200-day simple moving average is $58.78. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.08 by $0.01. The business had revenue of $95.43 billion for the quarter, compared to analysts’ expectations of $92.72 billion. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The company’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same period in the prior year, the firm earned $2.21 EPS. As a group, equities analysts expect that CVS Health Co. will post 5.32 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, October 21st were given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 4.82%. The ex-dividend date of this dividend was Monday, October 21st. CVS Health’s dividend payout ratio is currently 67.51%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.